Anlon Healthcare Limited announced the outcome of its Board of Directors meeting held on October 13, 2026, which commenced at 5:30 PM IST and concluded at 7:30 PM IST.
The Board considered and approved a proposal for raising funds through the issuance of warrants convertible into equity shares on a preferential basis. The key details are:
Nature of Event: Fundraising via preferential issue of convertible warrants
Total Amount: Aggregate amount not exceeding ₹250,00,00,000 (Rupees Two Hundred and Fifty Crore Only)
Instrument Details:
- Warrants fully convertible into equivalent number of equity shares
- Face value of each equity share: ₹2
- Preferential issue in accordance with Chapter V of SEBI ICDR Regulations, 2018
- The issue will be undertaken for cash consideration
Investor Details:
1. Punitkumar Rameshbhai Rasadia (Promoter)
2. Meet Atulkumar Vachhani (Promoter)
3. Smart Horizon Capital Advisors Private Limited (Public)
4. Ploutos Plus Consultant Private Limited (Public)
Conversion Terms:
- Each warrant convertible into one equity share
- Minimum 25% of consideration payable on date of allotment
- Balance 75% payable at time of allotment of equity shares upon exercise of conversion option
- Conversion period: 18 months from date of warrant allotment
- If conversion option not exercised within 18 months, consideration amount stands forfeited
Pending Decisions:
- Number of warrants to be issued
- Price of the warrants
- Date of shareholders meeting
- These matters will be decided in subsequent board meeting
Regulatory Compliance:
- Disclosure made under Regulation 30 of SEBI Listing Regulations
- Reference to SEBI Master Circular: HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026
Company Information:
- Contact: +91-7069690081/82 | info@anlonhealthcare.com